Whether the Senate version of health reform policy that was released as a draft today is a viable option will be decided by Congress as early as next week. Here is the least you need to know.
We know catching the bad guy is too little too late—the patient has already been hurt by then. Maybe the real investment should be in educating the public with an unprecedented campaign.
President Trump and HHS Secretary Tom Price have identified three excellent priorities—childhood obesity, mental illness and the opioid epidemic—but their actions seem to be counterproductive. What do you think?
President Trump nominated psychiatrist Elinore McCance-Katz for a new assistant secretary position, but some wonder if she will transform SAMHSA's accountability as envisioned.
I am reassured that addiction remains a bipartisan issue, which is vitally important in our national dialogue today.
Behavioral healthcare stakeholders might have a reason to drop what they’re doing—right now—and get on the phone to anyone in Washington who will listen.
Everyone’s talking about the healthcare bill House Republicans released Monday night. Here’s the very least you need to know.
In the fragmented healthcare system, prescription drug monitoring programs might be valuable in avoiding opioid prescription fills for buprenorphine patients.
For the future, one of the most pressing questions to ask will be how industry leaders might separate malice from ignorance.
Future healthcare policy will undoubtedly be driven by cost, whether it’s the Trump administration’s anticipated replacement for ACA or the iterations of adjustments down the road.
Julie Miller has more than 14 years of experience observing, analyzing and reporting on various...
View issues archive
Get the Digital Edition